Today: 7 February 2026
Subscribe
Browse Category

NYSE:BTI News 24 November 2025

British American Tobacco on 24 November 2025: Buybacks, Institutional Demand and Dividend Strength Keep BTI/BATS in Focus

British American Tobacco on 24 November 2025: Buybacks, Institutional Demand and Dividend Strength Keep BTI/BATS in Focus

LONDON — 24 November 2025 — British American Tobacco p.l.c. (BAT), traded as BATS in London and BTI in New York, stayed firmly on investors’ radar today as a new round of share buybacks, fresh institutional inflows and renewed attention on its hefty dividend confirmed how central the tobacco giant remains to income-focused portfolios. While no major trading update or profit warning hit the wires, a cluster of regulatory announcements and fund-flow data on 24 November paints a clear picture: BAT is still leaning heavily on buybacks and dividends to support shareholder returns as it navigates regulatory pressure and a leadership transition. Share buyback
24 November 2025
··
1 2

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop